The farnesoid X receptor agonist EDP‐305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction-Reference-Cited by-同舟云学术

The farnesoid X receptor agonist EDP‐305 reduces interstitial renal fibrosis in a mouse model of unilateral ureteral obstruction

Published:2019-03-18 Issue:6 Volume:33 Page:7103-7112
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Li Shen¹,Ghoshal Sarani¹,Sojoodi Mozhdeh¹,Arora Gunisha¹,Masia Ricard²,Erstad Derek J.¹,Ferriera Diego S.³,Li Yang⁴,Wang Guogiang⁴,Lanuti Michael¹,Caravan Peter⁵³,Or Yat Sun⁴,Jiang Li-Juan⁴,Tanabe Kenneth K.¹,Fuchs Bryan C.¹

Affiliation:

1. Division of Surgical OncologyMassachusetts General Hospital Cancer CenterHarvard Medical SchoolBostonMassachusettsUSA

2. Department of PathologyMassachusetts General Hospital Cancer CenterHarvard Medical SchoolBostonMassachusettsUSA

3. Martinos Center for Biomedical ImagingMassachusetts General HospitalHarvard Medical SchoolCharlestownMassachusettsUSA

4. Enanta PharmaceuticalsWatertownMassachusettsUSA

5. Institute for Innovation in ImagingMassachusetts General Hospital Cancer CenterHarvard Medical SchoolBostonMassachusettsUSA

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1096/fj.201801699R

Reference39 articles.

1. Renal fibrosis: New insights into the pathogenesis and therapeutics

2. The State of Chronic Kidney Disease, ESRD, and Morbidity and Mortality in the First Year of Dialysis

3. Cellular and molecular mechanisms of renal fibrosis

4. Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage

5. The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bile Acids and Farnesoid X Receptor in Renal Pathophysiology;Nephron;2024-02-27

2. Altenusin, a fungal metabolite, alleviates TGF-β1-induced EMT in renal proximal tubular cells and renal fibrosis in unilateral ureteral obstruction;Heliyon;2024-02

3. Dual soluble epoxide hydrolase inhibitor – farnesoid X receptor agonist interventional treatment attenuates renal inflammation and fibrosis;Frontiers in Immunology;2024-01-03

4. Noninvasive Quantification of Radiation-Induced Lung Injury Using a Targeted Molecular Imaging Probe;International Journal of Radiation Oncology*Biology*Physics;2023-12

5. Noninvasive Quantification of Radiation-Induced Lung Injury using a Targeted Molecular Imaging Probe;2023-09-26